Introduction
CHARGE syndrome is characterized by multiple congenital anomalies and affects approximately 1 child per 10,000 live births [1, 2] . It is named after its 6 cardinal clinical features: coloboma, heart malformation, atresia choanae, retarded growth and development, genital hypoplasia, and ear abnormalities. Mutations in the gene encoding chromodomain helicase DNA-binding protein 7 (CHD7) are responsible for the development of CHARGE syndrome. Disease-causing mutations in CHD7 are found in 60-70% patients with CHARGE syndrome [3] [4] [5] . Although CHARGE syndrome can be clinically diagnosed immunodeficiency in Korea, with a prevalence rate of 0.5 per million [10] . Auditory abnormality is the main manifestation of CHARGE syndrome. Immunodeficiency and hypocalcemia are rarely reported and have not been previously described in Korean patients with CHARGE syndrome [3] .
Here, we report the case of a patient with CHARGE syndrome who also developed immunodeficiency and hypocalcemia.
Case
A 58-day-old girl was transferred to our hospital because of recurrent tetany. She was born to a healthy mother through an emergency cesarean section because of fetal deceleration at 39 weeks of gestation. Her Apgar scores were 6 and 7 at 1 and 5 minutes, respectively. Her birth weight, height, and head circumference were 2,960 g (25th-50th percentile), 50 cm (50th-75th percentile), and 34 cm (50th-75th percentile), respectively. After birth, the girl was transferred to a tertiary hospital for further management. Biochemical analysis of her serum sample indicated hypocalcemia (ionized calcium, 3.01 mg/dL; total calcium, 7.3 mg/dL), which was normalized by intravenous infusion of calcium. After this, her calcium level remained within the normal range without further treatment. Results of other neonatal screening tests, including auditory screening by measuring automated auditory brainstem response, were normal. Echocardiography showed an atrial septal defect of permanent foramen ovale type and small patent ductus arteriosus. The patient had developmental dysplasia of the hip that was treated using a Pavlik harness. She also had a high-arched palate with a soft tissue cleft. Because she showed a poor ability to suck, she was fed by gavage. She was discharged at 25 days of age.
Biochemical analysis of her serum sample performed at 58 days of age (when she was transferred to our hospital because of recurred tetany) indicated hypocalcemia (ionized calcium, 1.84 mg/dL; total calcium, 3.9 mg/dL), hyperphosphatemia (13.6 mg/dL), normal alkaline phosphatase level (259 IU/L), low 25-hydroxyvitamin D level (19.4 ng/mL), and low parathyroid hormone level (3.0 pg/mL). Her face was square, with a broad, flat nose, and she had micrognathia and a short neck. Her face became asymmetric while crying, suggesting right facial nerve palsy. Both her ears were low set and dysmorphic, with the left ear being mildly constricted and the right ear being cup shaped. Her parents were healthy and unrelated, and her only brother had no problems that required medical attention.
Auditory-evoked potential testing showed sensorineural deafness, and ophthalmic examination showed coloboma of the left eye. Abdominal ultrasonography showed hydronephrosis of both the kidneys. Chest radiography did not detect a thymic shadow. Her hypocalcemia was treated by intravenous infusion of calcium followed by oral administration of calcium and vitamin D. Because she was suspected of having 22q11.2 deletion syndrome, we performed chromosomal analysis, array comparative genomic hybridization, and fluorescent in situ hybridization. The results of these analyses showed that she had a normal 46, XX karyotype, with benign copy number variations in chromosomes Xq27.2, Xq28, 12p13.31, and 22q11.22 and no deletion of chromosome 22q11.2. She still showed poor swallowing and was fed by gavage. She was discharged at 70 days of age after stabilization of her calcium levels. At 5 months of age, she was re-admitted to our hospital because of pneumonia. Before admission, she experienced frequent aspiration even of saliva during tube feeding. On the seventh day of hospitalization, her pneumonia exacerbated to acute respiratory distress syndrome (ARDS) because of which she was given mechanical ventilation. Previously noted lymphadenitis on her left axillar after BCG vaccination became suppurative, and scattered papules on her left leg were newly developed. Tissue biopsy of the scattered papules showed chronic granulomatous inflammation. Because of the risk of BCG dissemination, she was treated using isoniazid, rifampin, and ethambutol. Her immune status was evaluated because she experienced repeated, unusual, and severe infection. Lymphocyte surface marker analysis showed normal to increased number of total lymphocytes (24-27%), white blood cells (3,500-5,100/µL), T lymphocytes (900-2,800/ µL), B lymphocytes (1,500-2,500/µL), and natural killer cells (500-1,000/µL); low number of CD4 cells (260-550/µL); and inverse ratio of CD4/CD8 cells (0.2-0.4). Immunoglobulin analysis showed low levels of normal immunoglobulin (Ig) G (231 mg/dL) and normal levels of IgM (33 mg/dL) and IgA (7 mg/dL). After intensive care with antibiotics and intravenous immunoglobulins, her condition finally improved, and she was discharged at 8 months of age. An esophagogram obtained at the time of discharge did not show tracheoesophageal fistula or gastroesophageal reflux.
At 9 months of age, the girl was re-admitted to our hospital because of pneumonia. At that time, her body weight was 5.2 kg (<3rd percentile) and her height was 59 cm (<3rd percentile). She showed developmental delay such as inability to rotate her trunk and sit alone. Immunoglobulin analysis showed low IgG level (216 mg/dL). She was given mechanical ventilation because of pneumonia with ARDS. Examination of tracheal aspirate detected continuous infection of parainfluenza virus and intermittent infection of Pseudomonas aeruginosa, Acinetobacter baumannii, methicillin-resistant Staphylococcus aureus , and Candida albicans. Treatment with appropriate antibiotics and antifungals as well as intravenous infusion of immunoglobulins could not treat the pneumonia. Finally, she died because of ventilator-associated pneumonia and sepsis at 13 months of age. Subsequent mutation analysis of CHD7 showed a pathogenic c.2238+1G>A mutation (Fig. 1) , which has been previously reported in patients with CHARGE syndrome.
Discussion
According to the Verloes criteria [1] , our patient had at least atypical CHARGE syndrome satisfying one major (coloboma) and three minor (facial palsy, abnormal external ear, and heart defect) criteria. In addition, her clinical features were similar to those of patients with CATCH22 syndrome; however, she did not show chromosome 22q11.2 deletion. Because clinical features of CHARGE syndrome are similar to those of 22q11.2 deletion syndrome, it is difficult to differentiate between the two syndromes on the basis of phenotypes alone (phenotypes of our patient are reported in Table 1 ). CHARGE syndrome can be easily diagnosed in boys because of the presence of genital hypoplasia. However, this feature was not observed in our female patient. Overlapping features of CHARGE and 22q11.2 deletion syndromes suggest a common neural crest defect and a mechanism that is partly explained by TBX1, a major candidate gene involved in 22q11.2 deletion syndrome. This gene may be a functional target of CHD7. Alternatively, these 2 syndromes may involve common target genes in affected organs [6, 11, 12] . Most patients develop CHARGE syndrome sporadically because of de novo mutations in CHD7. Our patient seemed to be the only affected member in her family. Molecular examination of our patient showed a pathogenic splicing mutation in CHD7 and benign copy number variations in chromosomes 12p, 22q, and Xq but no 22q11.2 deletion [4, 13] .
Although the frequency and nature of immunodeficiencies in patients with CHARGE syndrome have not been analyzed appropriately, these immunodeficiencies may be more common in patients with CHARGE syndrome than in patients with 22q11.2 deletion syndrome [6, 7] . The close association between lymphopenia and hypocalcemia in patients with CHARGE syndrome suggests that they develop because of impaired embryogenesis, which is similar to that observed in patients with 22q11.2 deletion syndrome [7] . Because most Korean infants Frequency is shown as the number of patients with a feature/number of patients investigated. Data are based on information provided by Corsten-Janssen et al. [6] . +, present; -, not present; -, undetermined. a Frequencies showing higher agreement with the features of our patient.
receive BCG vaccination before 1 month of age, an unusual reaction to the BCG vaccine should alert clinicians about the possibility of primary immunodeficiencies. The severity of immunodeficiencies in patients with CHARGE syndrome ranges from mild to severe T lymphocyte deficiency and isolated humoral immunodeficiency, which is similar to that in patients with 22q11.2 deletion syndrome. Although functional analysis of T lymphocytes was not performed in our patient, most patients with CHARGE syndrome have decreased number and poorly functional T lymphocytes [14] . Oligoclonal expansion of poorly functional T lymphocytes results in normal or mildly decreased number of T lymphocytes, which may impede the diagnosis of immunodeficiency [14] . Isolated humoral immunodeficiency is rare. Low IgG level in our patient may reflect impaired number and decreased function of CD4 cells. Although the immune system of our patient was not severely affected, IgG deficiency along with velopharyngeal incoordination contributed to the recurrent and uncontrolled airway infections and finally death. This is the first case of mutation-confirmed CHARGE syndrome with immunodeficiency and hypocalcemia in Korea. Before the availability of CHD7 mutation analysis, patients with overlapping features of CHARGE and 22q11.2 deletion syndromes and concomitant immunodeficiency and hypocalcemia were likely to be diagnosed as having DiGeorge syndrome. Patients with overlapping features of CHARGE and 22q11.2 deletion syndromes should be suspected of having CHARGE syndrome, especially in the absence of chromosome 22q11.2 deletion, because these patients almost always show some degree of hearing loss, which requires appropriate auditory evaluation for accurate management [15] . In addition, immunological evaluation of all patients with CHARGE syndrome should be performed to estimate their immune function and to provide proper management for infectious illnesses.
In conclusion, clinical diagnosis of CHARGE and 22q11.2 deletion syndromes is challenging. Our observations suggest that mutation analysis of CHD7 should be performed for patients who have phenotypes of 22q11.2 deletion syndrome but do not have the chromosomal microdeletion. In addition, we propose that all patients with CHARGE syndrome should be evaluated for immunodeficiency and hypocalcemia.
